How UroGen Pharma uses its cash

Period

FY2016

Where does UroGen Pharma's cash go? This Sankey traces cash from net income through operating cash flow into capex, free cash flow, dividends, buybacks, and debt paydown. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

UroGen Pharma Ltd. · FY2016 · year ended 2016-12-31

Operating cash flow$4MCash from operations$6M · 100%D&A$213000 · 3%Stock comp$2M · 32%Working capital$4M · 64%Covers net loss$2M · 32%Capex$695000 · 11%Free cash flow$3M · 57%Cash retained$3M · 57%

Each fiscal year from SEC filings. Percentages are share of operating cash flow. Sources (net income + non-cash add-backs) flow into operating cash flow, which splits into capex and free cash flow; free cash flow goes to dividends, buybacks, debt paydown, and what's retained. Annual only. For informational purposes only.